Pharma - 'Buy' Ipca, 'Add' Lupin, Avoid Dr. Reddy's Among Others Says HDFC Securities Ahead Of Q3 Results
Pharma, Healthcare Q3 Results Preview - The brokerage foresees strong performances from Lupin, Torrent, Ipca and Apollo Hospital, while Aurobindo and Max Healthcare may show more muted results.
from NDTV Profit https://ift.tt/pJVtZie
from NDTV Profit https://ift.tt/pJVtZie
Pharma - 'Buy' Ipca, 'Add' Lupin, Avoid Dr. Reddy's Among Others Says HDFC Securities Ahead Of Q3 Results
Reviewed by aamira sultan
on
January 14, 2025
Rating: